Kostas Konstantopoulos Selected Research

Kostas Konstantopoulos Research Topics

Disease

9	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 03/2016
5	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021 - 03/2002
4	B-Cell Lymphoma (Lymphoma, B Cell) 05/2022 - 01/2021
4	beta-Thalassemia (Cooley's Anemia) 09/2006 - 01/2002
2	Hemolysis 01/2021 - 07/2019
2	Inflammation (Inflammations) 07/2019 - 07/2017
2	Multiple Myeloma 11/2017 - 12/2015
2	Thrombosis (Thrombus) 07/2017 - 01/2010
2	Thalassemia 01/2010 - 09/2006
2	Osteoporosis 09/2006 - 06/2006
2	Bone Resorption 09/2006 - 06/2006
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2022
1	COVID-19 10/2021
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Progressive Multifocal Leukoencephalopathy 01/2021
1	Anemia 11/2019
1	Jaundice (Icterus) 11/2019
1	Fever (Fevers) 11/2019
1	Iron Overload 07/2019
1	Primary Myelofibrosis (Myelosclerosis) 01/2019
1	Essential Thrombocythemia 01/2019
1	Hypercalcemia (Milk Alkali Syndrome) 11/2017
1	Carcinogenesis 07/2017
1	Neoplasms (Cancer) 07/2017
1	Hemolytic Anemia 01/2017
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 12/2015
1	Vitamin D Deficiency 09/2015
1	Diabetes Mellitus 09/2015
1	Behcet Syndrome (Behcet's Syndrome) 03/2011
1	alpha-Thalassemia 01/2010
1	Polycythemia (Erythrocytosis) 01/2010
1	Influenza in Birds (Avian Flu) 11/2008
1	Pain (Aches) 09/2006
1	Osteosclerosis 06/2006
1	Familial Mediterranean Fever (Periodic Disease) 01/2005
1	Sepsis (Septicemia) 01/2002
1	Hemorrhage 01/2002
1	Disseminated Intravascular Coagulation 01/2002
1	Bacteremia 01/2002

Drug/Important Bio-Agent (IBA)

3	Rituximab (Mabthera)FDA Link 05/2022 - 08/2021
3	Brentuximab VedotinIBA 04/2021 - 11/2019
3	Hemoglobins (Hemoglobin)IBA 01/2021 - 01/2005
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2021 - 02/2017
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2019
2	OsteoprotegerinIBA 09/2006 - 06/2006
1	Monoclonal AntibodiesIBA 05/2022
1	Ferritins (Ferritin)IBA 01/2022
1	COVID-19 VaccinesIBA 10/2021
1	polatuzumab vedotinIBA 08/2021
1	Bendamustine Hydrochloride FDA Link 08/2021
1	obinutuzumabIBA 01/2021
1	Gemcitabine FDA Link 11/2019
1	Vinorelbine (Navelbine)FDA LinkGeneric 11/2019
1	superoxide dismutase 2IBA 07/2019
1	CalreticulinIBA 01/2019
1	CalciumIBA 11/2017
1	Plasminogen Activators (Plasminogen Activator)IBA 07/2017
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 07/2017
1	Plasminogen Activator Inhibitor 1IBA 07/2017
1	plasma protein Z (protein Z)IBA 07/2017
1	Messenger RNA (mRNA)IBA 02/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017
1	ThioredoxinsIBA 01/2017
1	InterferonsIBA 01/2017
1	CXC ChemokinesIBA 01/2017
1	Bleomycin (Blenoxane)FDA LinkGeneric 03/2016
1	Dacarbazine (DIC)FDA LinkGeneric 03/2016
1	Vinblastine (Vinblastine Sulfate)FDA Link 03/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2016
1	Glucose (Dextrose)FDA LinkGeneric 09/2015
1	Insulin (Novolin)FDA Link 09/2015
1	25-hydroxyvitamin DIBA 09/2015
1	hydroxide ionIBA 09/2015
1	AntibodiesIBA 03/2011
1	AnticoagulantsIBA 01/2010
1	Oxygen (Dioxygen)IBA 01/2010
1	GlobinsIBA 01/2010
1	hemoglobin OlympiaIBA 01/2010
1	VaccinesIBA 11/2008
1	Zoledronic Acid (Zometa)FDA Link 09/2006
1	OsteocalcinIBA 09/2006
1	Procollagen Type IIBA 09/2006
1	OsteopontinIBA 09/2006
1	Collagen Type I (Type I Collagen)IBA 09/2006
1	collagen type I trimeric cross-linked peptideIBA 09/2006
1	Alkaline PhosphataseIBA 09/2006
1	PyrinIBA 01/2005
1	IronIBA 03/2002
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2002

Therapy/Procedure

4	Radiotherapy 01/2022 - 01/2021
3	Drug Therapy (Chemotherapy) 01/2022 - 07/2019
2	Stem Cell Transplantation 07/2019 - 12/2015
1	Immunotherapy 07/2019
1	Therapeutics 11/2017